Phase II trial of standard dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and Rituximab (R-CHOP) plus bevacizumab for advanced stage diffuse large B-Cell (DLBCL) NHL: Southwest oncology group study S0515

Category Primary study
JournalBlood
Year 2010
This article has no abstract
Epistemonikos ID: a80288018f8c32ce773ec44489181ecd27769d6e
First added on: Feb 05, 2025